Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000009253 | SCV002237502 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2E | 2022-08-01 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 8715). This variant is also known as 'FS164TER'. This premature translational stop signal has been observed in individual(s) with SGCB-related conditions (PMID: 8968749). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Glu156Lysfs*9) in the SGCB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SGCB are known to be pathogenic (PMID: 15938573, 18285821). |
Mendelics | RCV000009253 | SCV002519716 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2E | 2022-05-04 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000009253 | SCV000029471 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2E | 1996-12-01 | no assertion criteria provided | literature only |